There is a magic when Medical and AI ethics are best friends
Unleashing opportunities for better understanding and collaboration between experts in AI and medical
Unleashing opportunities for better understanding and collaboration between experts in AI and medical
“If you ask patient communities their major concerns, it’s affordable access,” says Alissa Heizler-Mendoza speaking about patient advocacy in Medical Affairs.
MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.
In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
The webinar will provide a snapshot of insights on what matters to patients and how pharma fares in terms of patient centricity based on a new patient centricity benchmarking survey piloted in 2019.
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
This session describes the National Health Council​ and opportunities for Medical Affairs professionals to get involved.
J&J leaders detail how to think about managing the challenge of broadening the focus of a Medical Affairs career to encompass new and multiple therapeutic areas.
This MAPS podcast identifies potential areas for compliant collaboration by medical science liaisons with key internal Medical Affairs partners
A 2020 MAPS white paper highlights that while the metrics for departments such as R&D (new product approvals) and Commercial (sales) are clear, a single performance indicator that can measure the value of MA is lacking. While important metrics exist, such as time to publication submission and customer satisfaction, Share of Scientific Voice (SoSV) measures scientific impact and can serve as an objective and strategic performance metric for MA.
The measurement of SoSV is derived from the number of relevant mentions across scientific disseminations, relative to alternatives in the same therapeutic area. These clear outputs correlate with several activities that MA professionals lead across the MAPS-defined key pillars for MA - insights, evidence generation and evidence dissemination. This work is highly strategic and valuable for an organisation, as it shapes product strategy, closes data gaps, forms the scientific narrative and educates healthcare professionals. Therefore, SoSV provides a valuable metric for the performance and progress of MA.
This webinar will review the rationale for SoSV as a performance metric in MA, how it is implemented in practice, and examine how it can be used strategically to measure, prioritize and achieve success.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.